Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

3.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.9K
Development of Blood Vessels01:07

Development of Blood Vessels

1.7K
The development of the vascular system in a fetus is a complex and intricate process that begins as early as 15 to 16 days post-conception. This process starts outside the embryo, specifically in the mesoderm of the yolk sac, chorion, and connecting stalk. Approximately two days later, the formation of blood vessels occurs within the embryo itself.
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...
1.7K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

7.4K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
7.4K
Disorders of Hemostasis01:24

Disorders of Hemostasis

2.6K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.6K
Veins of Head and Neck01:19

Veins of Head and Neck

6.6K
The blood drainage from the head and neck is primarily managed by three pairs of veins: the external jugular, internal jugular, and vertebral veins. The external jugular veins drain superficial scalp and face structures, passing over the sternocleidomastoid muscles to empty into the subclavian veins.
On the other hand, the vertebral veins, unlike their arterial counterparts, are not primarily responsible for brain drainage. Instead, they drain the cervical vertebrae, spinal cord, and some small...
6.6K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

4.9K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High cancer-associated mutational burden in normal blood of xeroderma pigmentosum group C, but not groups A, D, or F.

Blood neoplasia·2026
Same author

Building consensus in pediatric dermatology research.

The Journal of investigative dermatology·2026
Same author

Enteral Green Beans in the Management of Neonatal Irritant Diaper Dermatitis.

Pediatric dermatology·2026
Same author

Use of dupilumab in eczematous eruptions following hematopoietic cell transplantation.

JAAD case reports·2025
Same author

Basal cell carcinoma risk prediction in survivors of childhood cancer.

Journal of the National Cancer Institute·2025
Same author

Multifocal Kaposiform Hemangioendothelioma Successfully Treated With Sirolimus Monotherapy.

Pediatric dermatology·2025
Same journal

Systemic therapy for advanced cutaneous squamous cell carcinoma.

Seminars in cutaneous medicine and surgery·2019
Same journal

Atypical Fibroxanthoma.

Seminars in cutaneous medicine and surgery·2019
Same journal

Introduction, High-Risk Skin Cancer.

Seminars in cutaneous medicine and surgery·2019
Same journal

Emerging technologies for health information in dermatology: opportunities and drawbacks of web-based searches, social media, mobile applications, and direct-to-consumer genetic testing in patient care.

Seminars in cutaneous medicine and surgery·2019
Same journal

MoleMapper: an application for crowdsourcing mole images to advance melanoma early-detection research.

Seminars in cutaneous medicine and surgery·2019
Same journal

Digital imaging applications and informatics in dermatology.

Seminars in cutaneous medicine and surgery·2019
See all related articles

Related Experiment Video

Updated: Mar 15, 2026

Laparoscopic Anatomical Right Hemihepatectomy via the In Situ Anterior Approach
05:30

Laparoscopic Anatomical Right Hemihepatectomy via the In Situ Anterior Approach

Published on: August 8, 2025

683

Congenital hemangiomas.

Christina Boull1, Sheilagh M Maguiness2

  • 1Department of Dermatology, Division of Pediatric Dermatology, University of Minnesota, Minneapolis, Minnesota, USA. oehr0005@umn.edu.

Seminars in Cutaneous Medicine and Surgery
|September 9, 2016
PubMed
Summary
This summary is machine-generated.

Congenital hemangiomas are rare vascular tumors classified as rapidly involuting (RICHs) or noninvoluting (NICHs). While NICHs persist, RICHs involute quickly, though hepatic RICHs can cause cardiac failure.

Keywords:
NICHPICHRICHRICH-FIRICH-fetal involutioncongenital hemangiomanoninvoluting congenital hemangiomapartially involuting congenital hemangiomarapidly involuting congenital hemangioma

More Related Videos

A Patient-Derived Xenograft Model for Venous Malformation
06:51

A Patient-Derived Xenograft Model for Venous Malformation

Published on: June 15, 2020

5.8K
A Comprehensive Procedure to Evaluate the In Vitro Performance of the Putative Hemangioblastoma Neovascularization Using the Spheroid Sprouting Assay
08:26

A Comprehensive Procedure to Evaluate the In Vitro Performance of the Putative Hemangioblastoma Neovascularization Using the Spheroid Sprouting Assay

Published on: April 12, 2018

8.6K

Related Experiment Videos

Last Updated: Mar 15, 2026

Laparoscopic Anatomical Right Hemihepatectomy via the In Situ Anterior Approach
05:30

Laparoscopic Anatomical Right Hemihepatectomy via the In Situ Anterior Approach

Published on: August 8, 2025

683
A Patient-Derived Xenograft Model for Venous Malformation
06:51

A Patient-Derived Xenograft Model for Venous Malformation

Published on: June 15, 2020

5.8K
A Comprehensive Procedure to Evaluate the In Vitro Performance of the Putative Hemangioblastoma Neovascularization Using the Spheroid Sprouting Assay
08:26

A Comprehensive Procedure to Evaluate the In Vitro Performance of the Putative Hemangioblastoma Neovascularization Using the Spheroid Sprouting Assay

Published on: April 12, 2018

8.6K

Area of Science:

  • Vascular Surgery
  • Pediatric Oncology
  • Dermatology

Background:

  • Congenital hemangiomas are rare, solitary vascular tumors.
  • They are categorized into rapidly involuting congenital hemangiomas (RICHs) and noninvoluting congenital hemangiomas (NICHs) based on clinical behavior.
  • NICHs are persistent without complications, whereas RICHs involute rapidly in infancy but may present with early ulceration or bleeding.

Purpose of the Study:

  • To review the clinical characteristics of congenital hemangiomas.
  • To discuss current management strategies for congenital hemangiomas.
  • To highlight specific considerations for hepatic RICHs.

Main Methods:

  • Literature review of clinical characteristics.
  • Analysis of management approaches for congenital hemangiomas.
  • Review of case studies and clinical progression data.

Main Results:

  • Congenital hemangiomas do not proliferate postnatally.
  • Hepatic RICHs can lead to high-output cardiac failure due to abnormal shunting.
  • RICHs involute within the first few months of life, while NICHs are persistent.

Conclusions:

  • Understanding the distinct clinical courses of RICHs and NICHs is crucial for diagnosis and management.
  • Early recognition of hepatic RICHs is vital to prevent complications like cardiac failure.
  • Current management focuses on differentiating between RICHs and NICHs and addressing associated complications.